FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA supplemental approval for Methimazole involving Chartwell RX, LLC under an ANDA, confirming regulatory status for a generic methimazole product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease
• Hyperthyroidism

Drugs mentioned

• Methimazole (Methimazole)

Snippet

SUPPL AP for METHIMAZOLE (METHIMAZOLE)